January 1. 2015 | The Israeli company Brainsway, developing a unique treatment for brain disorders, announced that due to increased interest in the United States, it will launch a subsidiary in the US. Brainsway USA is already working towards recruiting key personnel and is working towards building a versatile team of employees that will expand the company in the US. Brainsway develops and markets Deep TMS (Deep Transcranial Magnetic Stimulation) systems for the treatment of brain disorders, a technology based on patents filed with the National Institutes of Health. The use of the company’s technology for the treatment of depression was recently approved by the US Food & Drug Administration.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
![](https://nocamels.com/wp-content/uploads/2018/02/INSIGHTEC-350x180.jpg)
Israeli Ultrasound Creator Collaborating On Neuroscience R&D In US
September 05, 2024
![The Weizmann Institute of Science. Photo via the Weizmann Institute of Science](https://nocamels.com/wp-content/uploads/2018/07/weizmann-350x252.jpg)
Weizmann In World’s Top 10 For Biomedical And Overall Research
September 05, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/Depositphotos_75148477_L-350x228.jpg)
Israeli NGO Begins New Mental Health Training In Ukraine
September 04, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/17123254699_79ff768811_ks-350x213.jpg)
Nonprofit Launches Loans For Stricken Northern Israel Businesses
September 04, 2024
Facebook comments